Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew H Porteus

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
The CRISPR Journal|June 26, 2024
A Story of Perseverance: An Interview with Matthew PorteusMatthew H Porteus, Kevin Davies
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2013
A crisper look at genome editing: RNA-guided genome modificationMara Damian, Matthew H Porteus
Current Opinion in Hematology|August 15, 2017
The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translationDaniel P Dever, Matthew H Porteus
Current Opinion in Immunology|September 18, 2012
Development of nuclease-mediated site-specific genome modificationStacey E Wirt, Matthew H Porteus
Science (New York, N.Y.)|August 1, 2024
Cell and gene therapy accessibilityRayne H Rouce, Matthew H Porteus
Cell Reports|July 21, 2017
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor VectorsRasmus O Bak, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2019
AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCsAmanda M Dudek, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"Amanda M Dudek, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2015
Genome editing of the germline: broadening the discussionMatthew H Porteus, Christina T Dann
Immunological Reviews|January 18, 2024
Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacyHana Y Ghanim, Matthew H Porteus
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
The CRISPR Journal|June 26, 2024
A Story of Perseverance: An Interview with Matthew PorteusMatthew H Porteus, Kevin Davies
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2013
A crisper look at genome editing: RNA-guided genome modificationMara Damian, Matthew H Porteus
Current Opinion in Hematology|August 15, 2017
The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translationDaniel P Dever, Matthew H Porteus
Current Opinion in Immunology|September 18, 2012
Development of nuclease-mediated site-specific genome modificationStacey E Wirt, Matthew H Porteus
Science (New York, N.Y.)|August 1, 2024
Cell and gene therapy accessibilityRayne H Rouce, Matthew H Porteus
Cell Reports|July 21, 2017
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor VectorsRasmus O Bak, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2019
AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCsAmanda M Dudek, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"Amanda M Dudek, Matthew H Porteus
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2015
Genome editing of the germline: broadening the discussionMatthew H Porteus, Christina T Dann
Immunological Reviews|January 18, 2024
Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacyHana Y Ghanim, Matthew H Porteus
Pageof 15